Form 4: Jazz Pharma SVP Sells Shares for Tax Obligations

Jazz Pharmaceuticals' SVP of Technical Operations, Mary Elizabeth Henderson, sold 1,331 ordinary shares to cover tax liabilities from vested restricted stock units.

Summary

• Mary Elizabeth Henderson, SVP, Technical Operations at Jazz Pharmaceuticals plc, reported a transaction involving the disposition of ordinary shares.
• On November 19, 2025, Henderson sold 1,331 ordinary shares at a price of $180.4 per share.
• The sale was conducted to satisfy tax obligations arising from the vesting of previously granted restricted stock units.
• Following this transaction, Henderson directly beneficially owns 21,746 ordinary shares.

Sentiment

Score: 5

Explanation: The transaction is a routine sale of shares to cover tax obligations upon the vesting of restricted stock units, which is a common occurrence for executives receiving equity compensation. It does not indicate a change in management's confidence or the company's prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Management Comments

• Shares were sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Industry Context

This Form 4 filing reports a routine insider transaction for tax purposes and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The sale of shares by an executive, even for tax purposes, slightly increases the float but is generally not seen as a negative signal of company health or future prospects when it's a routine tax-related event.

Key Dates

Keywords

Jazz Pharmaceuticals, JAZZ, Form 4, Insider Transaction, Stock Sale, Tax Obligations, Restricted Stock Units, Mary Elizabeth Henderson, SVP Technical Operations